Yuying Li

A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy

Junhan Yang, Yang Wang, Binlei Liu, 2022, Virology journal.

NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors.

Qin Zhou, Yang Wang, Binlei Liu, 2021, Translational research : the journal of laboratory and clinical medicine.

The construction of a new oncolytic herpes simplex virus expressing murine interleukin‐15 with gene‐editing technology

Junhan Yang, Han-Shu Hu, Binlei Liu, 2020, Journal of medical virology.